DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.
DNA methylation plays a critical role in chromatin remodeling and gene expression. DNA methyltransferases (DNMTs) are hypothesized to mediate cellular DNA methylation status and gene expression during mammalian development and in malignant diseases. In this study, we examined the role of DNA methyltransferase 1 (DNMT1) and DNMT3b in cell proliferation and survival of hepatocellular carcinoma (HCC) cells. Gene silencing of both DNMT1 and DNMT3b by targeted siRNA knockdown reduces cell proliferation and sensitizes the cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell death. The proapoptotic protein caspase-8 demonstrated promoter hypermethylation in HCC cells and was up-regulated by knockdown of DNMT1 and DNMT3b both at mRNA and protein levels. In addition, death receptor TRAIL-R2/DR5 (TRAIL receptor 2/death receptor 5) did not exhibit promoter hypermethylation in HCC cells but was also up-regulated by knockdown of DNMT1 and DNMT3b both at mRNA and protein levels. Consistent with this observation, the combined transfection of DNMT1-siRNA plus DNMT3b-siRNA enhanced formation of the TRAIL-death-inducing signaling complex formation in HCC cells. In conclusion, our data suggest that DNA methylation of specific genomic regions maintained by DNMT1 and DNMT3b plays a critical role in survival of HCC cells, and a simultaneous knockdown of both DNMT1 and DNMT3b may be a novel anticancer strategy for the treatment of HCC.
Kurita
Satoshi
S
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan. kurita.satoshi@mayo.edu
Higuchi
Hajime
H
Saito
Yoshimasa
Y
Nakamoto
Nobuhiro
N
Takaishi
Hiromasa
H
Tada
Shinichiro
S
Saito
Hidetsugu
H
Gores
Gregory J
GJ
Hibi
Toshifumi
T
D017209:Apoptosis; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D053181:Caspase 8 / Q000235:genetics*; D045744:Cell Line, Tumor; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D019175:DNA Methylation; D019008:Drug Resistance, Neoplasm; D020868:Gene Silencing; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D024101:Mitochondrial Proteins / Q000378:metabolism; D011401:Promoter Regions, Genetic; D034741:RNA, Small Interfering / Q000235:genetics; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000235:genetics* / Q000502:physiology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000494:pharmacology*; D015854:Up-Regulation; D000097584:DNA Methyltransferase 3B
D053181:Caspase 8; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; D024101:Mitochondrial Proteins; D034741:RNA, Small Interfering; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand; D000097584:DNA Methyltransferase 3B; C503369:GRAMD4 protein, human; C000619380:DNMT1 protein, human
Nature. 2002 Apr 4;416(6880):552-6
11932749
Mol Cell. 2009 Oct 23;36(2):219-30
19854132
Cancer Res. 2002 Apr 1;62(7):2157-61
11929838
Cancer Res. 2004 May 1;64(9):3137-43
15126351
J Biol Chem. 2003 Jan 3;278(1):454-61
12407100
Hepatology. 2001 Mar;33(3):561-8
11230735
J Biol Chem. 2004 Jan 2;279(1):51-60
14561739
J Biol Chem. 2002 Aug 2;277(31):28176-81
12015329
Cancer Res. 2006 Jan 15;66(2):729-35
16424002
J Biol Chem. 2003 Apr 25;278(17):14985-95
12576480
Nat Rev Genet. 2002 Jun;3(6):415-28
12042769
Nat Med. 2000 May;6(5):529-35
10802708
Cell. 1993 Apr 9;73(1):61-71
8462104
Oncogene. 2003 Mar 27;22(12):1866-71
12660822
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):684-9
9012845
Neoplasia. 2005 Jul;7(7):646-57
16026644
Cell. 1995 Oct 6;83(1):13-5
7553865
Hepatol Res. 2003 Jul;26(3):186-191
12850690
Cancer Res. 2003 Oct 1;63(19):6110-5
14559786
Nucleic Acids Res. 2003 May 1;31(9):2305-12
12711675
Nat Genet. 1999 Feb;21(2):163-7
9988266
Exp Cell Res. 2001 Jan 15;262(2):154-69
11139340
Nature. 1997 Oct 16;389(6652):745-9
9338788
Int J Cancer. 2003 Jul 1;105(4):527-32
12712445
Cancer Res. 2005 Dec 15;65(24):11469-77
16357155
Nat Genet. 2004 Jun;36(6):582-4
15156141
Curr Biol. 2003 Jul 15;13(14):1192-200
12867029
Curr Opin Oncol. 2000 Jan;12(1):68-73
10687732
Cell. 1999 Oct 29;99(3):247-57
10555141
Nat Genet. 2003 Jan;33(1):61-5
12496760
Cancer Res. 1996 Jun 1;56(11):2463-7
8653676
Nature. 2000 Apr 27;404(6781):1003-7
10801130
Oncogene. 2000 Mar 30;19(14):1735-43
10777207
Carcinogenesis. 2007 Jun;28(6):1264-8
17272309
Cancer Res. 2002 Nov 15;62(22):6456-61
12438235
Gastroenterology. 2005 Nov;129(5):1602-15
16285959
Cell Death Differ. 2003 Mar;10(3):356-64
12700635
Oncogene. 2006 Aug 24;25(37):5125-33
16607283
BMC Cancer. 2002 Nov 15;2:29
12433278
J Biol Chem. 2004 Jul 2;279(27):27915-27
15087453
Oncogene. 2009 Jul 23;28(29):2667-77
19465937
Mol Cell Biol. 2003 Jan;23(1):206-15
12482974
Hum Mol Genet. 2000 Oct;9(16):2395-402
11005794
Science. 1999 Dec 17;286(5448):2287-8
10636791
Clin Cancer Res. 2004 Nov 15;10(22):7484-9
15569978